Ablaze Pharma and Wenjiang District Government of Chengdu jointly signed a strategic agreement during the Conference of Major Advanced Manufacturing Projects by Foreign Direct Investment.   Under the agreement, about 26,000㎡ of industrial land was selected in the Chengdu Medical City, with an initial investment of $100 million to build-up an innovative R&D and manufacturing center for targeted radiation therapies, where five anti-tumor varieties are under research at present, varying from ...